Key facts
- GenAqua’s last known valuation is $2.0M (Dec 2025).
- It has raised $500K; the latest was Early Stage VC ($1.1M) in Jun 2026.
- Notable investors include Cohort Innovation Space, LX Health.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for GenAqua
- ·The full record, as it builds
Funding rounds
No funding rounds for GenAqua are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GenAqua
Developer of a point-of-use potable water disinfection platform designed to reduce bacterial contamination in healthcare environments. The company offers UVC LED-based disinfection with real-time monitoring, compact waterproof hardware suitable for varied water conditions, enabling healthcare facilities to reduce infection risk and maintain safer water access.
- Sector
- Business Products and Services (B2B)
- HQ
- Southport, Australia
- Founded
- 2023
- Employees
- 1
- Website
- genaqua.com.au/
- Ownership
- Privately Held (backing)
GenAqua doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GenAqua shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GenAqua in its N-PORT filings yet. We sweep new filings monthly.